Cedar Brook Financial Partners, LLC Stryker Corp Transaction History

Cedar Brook Financial Partners, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	BUY	$293.94 - $358.71 $3,527 - $4,304	12 Added 1.18%	1,027 $367,000
Q4 2023 Jan 12, 2024	BUY	$253.85 - $299.46 $14,469 - $17,069	57 Added 5.95%	1,015 $303,000
Q3 2023 Oct 17, 2023	BUY	$266.54 - $302.43 $31,451 - $35,686	118 Added 14.05%	958 $261,000
Q2 2023 Jul 05, 2023	BUY	$271.49 - $305.09 $2,171 - $2,440	8 Added 0.96%	840 $256,000
Q1 2023 Apr 04, 2023	BUY	$246.13 - $285.47 $204,780 - $237,511	832 New	832 $237,000
Q2 2022 Aug 12, 2022	SELL	$194.09 - $276.37 $148,090 - $210,870	-763 Closed	0 $0
Q1 2022 Apr 06, 2022	BUY	$245.33 - $277.77 $187,186 - $211,938	763 New	763 $204,000
Q3 2021 Nov 01, 2021	SELL	$248.9 - $280.09 $195,635 - $220,150	-786 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$242.95 - $267.0 $190,958 - $209,862	786 New	786 $204,000
Q1 2021 May 11, 2021	SELL	$221.01 - $248.82 $189,626 - $213,487	-858 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$202.01 - $245.04 $173,324 - $210,244	858 New	858 $210,000

2,228

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $146B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Cedar Brook Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cedar Brook Financial Partners, LLC with notifications on news.